Medtronic (MDT) capital expenditure was $1.9B in FY2026 (+2% YoY). The tables below show the complete quarterly and annual capital expenditure history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Capital Expenditure
Fiscal Year
Capital Expenditure
YoY
2026
$1.9B
+2%
2025
$1.9B
+17%
2024
$1.6B
+9%
2023
$1.5B
+7%
2022
$1.4B
+1%
2021
$1.4B
+12%
2020
$1.2B
+7%
2019
$1.1B
+6%
2018
$1.1B
-15%
2017
$1.3B
+20%
2016
$1.0B
+83%
2015
$571M
+44%
2014
$396M
-13%
2013
$457M
Recent Quarterly Capital Expenditure
Quarter
Capital Expenditure
Q2 2026
$503M
Q1 2026
$488M
Q3 2025
$468M
Q2 2025
$504M
Q1 2025
$459M
Q3 2024
$404M
Q2 2024
$520M
Q1 2024
$426M
Q3 2023
$461M
Q2 2023
$354M
Q1 2023
$378M
Q3 2022
$323M
Source: MDT on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.